Skip to content

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00184353
Enrollment
19
Registered
2005-09-16
Start date
2003-11-30
Completion date
2005-06-30
Last updated
2011-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm Metastases

Keywords

brain metastasis, signal to noise ratio, spectral resolution

Brief summary

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Interventions

None listed

Sponsors

The Royal Norwegian Ministry of Health
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* brain metastases

Exclusion criteria

* children * pregnancy

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026